Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease

Main Article Content

Henshaw Uchechi Okoroiwu *
Christopher Ogar Ogar
(*) Corresponding Author:
Henshaw Uchechi Okoroiwu | okoroiwuhenshaw@gmail.com

Abstract

Increased mean platelet volume (MPV) is associated with platelet reactivity and is a predictor of cardiovascular risk and unprovoked nervous thromboembolism. Mean platelet volume is a precise measure of platelet size. Studies have reported the use of MPV as a biomarker for predicting ischemic stroke in atrial fibrillation patients as well as in anticoagulant prescription and rhythm-control therapy. Moreover, MPV may predict cardiovascular event outcome following percutaneous coronary intervention in patients with coronary artery disease. MPV may predict residual platelet reactivity in dual antiplatelet therapy. Factors influencing MPV result were discussed. This review centered on the reports that MPV may be a biomarker of risk and prognosis of prevalent heart diseases.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biography

Henshaw Uchechi Okoroiwu, Hematology Unit, Department of Medical Laboratory Science, University of Calabar

Haematologist (MSc, PhD in view)